Enveric Biosciences (ENVB) Return on Invested Capital (2011 - 2020)
Enveric Biosciences (ENVB) posted Return on Invested Capital of 0.0% for Q3 2020, up 96.37% sequentially from 0.0% in Q2 2020, and little changed YoY from 0.0% in Q4 2019.
Enveric Biosciences (ENVB) Return on Invested Capital (2011 - 2020) Analysis & Trends
Enveric Biosciences has reported Return on Invested Capital for 8 years, with the latest figure at 0.0% in Q3 2020.
- Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.0% in Q3 2020, while the trailing twelve-month figure through Sep 2020 was 0.0% (changed 0.0% YoY) and the FY2019 annual result came in at 0.26%, up 23.0% from the prior year.
- Return on Invested Capital grew to 0.0% in Q3 2020 per ENVB's latest filing, from 0.0% in the prior quarter.
- Over five years, Return on Invested Capital peaked at 0.01% in Q2 2019 and troughed at 0.04% in Q3 2016.
- A 5-year average of 0.01% and a median of 0.01% in 2018 frame the typical range for Return on Invested Capital.
- The sharpest annual moves came in 2017 and 2019: Return on Invested Capital grew 3 bps in 2017, then decreased 1 bps in 2019.
- Over 5 years, Return on Invested Capital stood at 0.02% in 2016, then jumped by 55 bps to 0.01% in 2017, then soared by 150 bps to 0.01% in 2018, then plunged by 127 bps to 0.0% in 2019, then soared by 98 bps to 0.0% in 2020.
- According to Business Quant data, Return on Invested Capital over the past three periods registered 0.0%, 0.0%, and 0.0% for Q3 2020, Q2 2020, and Q1 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.17% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Enveric Biosciences | 5.66 Mn | -2.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 0.00% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | 0.01% |
| Mar 31, 2019 | 0.01% |
| Dec 31, 2018 | 0.01% |
| Sep 30, 2018 | 0.00% |
| Jun 30, 2018 | -0.01% |
| Mar 31, 2018 | -0.01% |
| Dec 31, 2017 | -0.01% |
| Sep 30, 2017 | -0.01% |
| Jun 30, 2017 | -0.01% |
| Mar 31, 2017 | -0.01% |
| Dec 31, 2016 | -0.02% |
| Sep 30, 2016 | -0.04% |
| Jun 30, 2016 | -0.03% |
| Mar 31, 2016 | -0.02% |
| Jun 30, 2013 | -0.05% |